Effects of initial use of half-maximal dose rosiglitazone-metformin combination therapy, compared with maximum dose rosiglitazone or metformin, on glucose metabolism in type 2 diabetes mellitus

被引：0
|
作者：
Choe, Charles
Christiansen, Louis
Edelman, Steven
Mudaliar, Sunder
Henry, Robert R.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [31] Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in Type 2 diabetes
    Virtanen, KA
    Hällsten, K
    Parkkola, R
    Lönnqvist, F
    Lönnroth, P
    Rönnemaa, T
    Knuuti, J
    Huupponen, R
    Nuutila, P
    DIABETOLOGIA, 2002, 45 : A251 - A251
  • [32] Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes
    Yuan, MS
    Melendez, PA
    Iwamoto, M
    Lee, JS
    Shoelson, SE
    DIABETES, 2002, 51 : A145 - A145
  • [33] Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
    Zinman, Bernard
    Harris, Stewart B.
    Neuman, Jan
    Gerstein, Hertzel C.
    Retnakaran, Ravi R.
    Raboud, Janet
    Qi, Ying
    Hanley, Anthony J. G.
    LANCET, 2010, 376 (9735): : 103 - 111
  • [34] Reductions in biomarkers, of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study
    Goldstein, Barry J.
    Weissman, Peter N.
    Wooddell, Margaret J.
    Waterhouse, Brian R.
    Cobitz, Alexander R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (09) : 1715 - 1723
  • [35] Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in Type 2 diabetes mellitus
    Kelley, DE
    McKolanis, TM
    Kelley, CA
    DIABETOLOGIA, 2002, 45 : A188 - A188
  • [36] Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in type 2 diabetes mellitus
    Kelley, DE
    Mckolanis, TM
    Kelley, CA
    DIABETES, 2002, 51 : A35 - A35
  • [37] Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus
    Nie, Jie-Ming
    Li, Hai-Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 2521 - 2526
  • [38] Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    Comaschi, M.
    Demlcheli, A.
    Di Pietro, C.
    Bellatreccia, A.
    Mariz, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 387 - 398
  • [39] Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study
    Bailey, CJ
    Bagdonas, A
    Rubes, J
    McMorn, SO
    Donaldson, J
    Biswas, N
    Stewart, MW
    CLINICAL THERAPEUTICS, 2005, 27 (10) : 1548 - 1561
  • [40] Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Huang, C.
    Garber, A.
    DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 643 - 649
12345